Prospective Study of Intravitreal Ranibizumab as a Treatment for Decreased Visual Acuity Secondary to Central Retinal Vein Occlusion
Author:
Publisher
Elsevier BV
Subject
Ophthalmology
Reference27 articles.
1. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study;Klein;Arch Ophthalmol,2008
2. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study;Cugati;Arch Ophthalmol,2006
3. Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire;Deramo;Arch Ophthalmol,2003
4. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders;Aiello;N Engl J Med,1994
5. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion;Boyd;Arch Ophthalmol,2002
Cited by 142 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Correlation between change in central subfield thickness and change in visual acuity in macular edema due to retinal vein occlusion: post hoc analysis of COPERNICUS, GALILEO, and VIBRANT;Graefe's Archive for Clinical and Experimental Ophthalmology;2022-06-24
2. Real-World Evidence for Treat-and-Extend Regimen of Ranibizumab Therapy for Macular Oedema Secondary to Branch Retinal Vein Occlusion;Pharmaceuticals;2022-01-03
3. Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT;Health Technology Assessment;2021-06
4. The influence of dead spaces and the designs of injectors on the amount of drug dose in intra-vitreal injection;European Journal of Ophthalmology;2020-11-26
5. Analysis of intravitreal bevacizumab treatment for macular oedema due to retinal vein occlusion;European Journal of Ophthalmology;2020-09-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3